{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:19:51Z","timestamp":1790968791422,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejrad.2023.111112","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T12:14:49Z","timestamp":1695816889000},"page":"111112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Liver fibrosis estimated using extracellular volume fraction obtained from dual-energy CT as a risk factor for hepatocellular carcinoma after sustained virologic response: A preliminary case\u2013control study"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-7512","authenticated-orcid":false,"given":"Kumi","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyohiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Gabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2023.111112_b0005","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejrad.2023.111112_b0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2023.111112_b0015","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMp1400986","article-title":"Curing chronic hepatitis C\u2014the arc of a medical triumph","volume":"370","author":"Chung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2023.111112_b0020","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3748\/wjg.v28.i1.96","article-title":"Risk of hepatocellular carcinoma after hepatitis C virus cure","volume":"28","author":"Luna-Cuadros","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejrad.2023.111112_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2014.03.012","article-title":"Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?","volume":"107","author":"Lee","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ejrad.2023.111112_b0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/apt.13939","article-title":"Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience","volume":"45","author":"Takyar","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejrad.2023.111112_b0040","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00261-017-1211-7","article-title":"Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel","volume":"42","author":"Horowitz","year":"2017","journal-title":"Abdom. Radiol. (NY)"},{"key":"10.1016\/j.ejrad.2023.111112_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109604","article-title":"Hepatic fibrosis grading with extracellular volume fraction from iodine mapping in spectral liver CT","volume":"137","author":"Yoon","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2023.111112_b0050","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00330-021-07706-2","article-title":"Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters","volume":"31","author":"Nagayama","year":"2021","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2023.111112_b0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/hepr.13205","article-title":"Dual-energy computed tomography for non-invasive staging of liver fibrosis: accuracy of iodine density measurements from contrast-enhanced data","volume":"48","author":"Sofue","year":"2018","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejrad.2023.111112_b0060","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11547-021-01341-z","article-title":"Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices","volume":"126","author":"Cicero","year":"2021","journal-title":"Radiol. Med."},{"key":"10.1016\/j.ejrad.2023.111112_b0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1148\/radiol.12112452","article-title":"Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT","volume":"266","author":"Varenika","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2023.111112_b0070","doi-asserted-by":"crossref","first-page":"20922","DOI":"10.1038\/s41598-020-77515-y","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejrad.2023.111112_b0075","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/cncr.20537","article-title":"Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy","volume":"101","author":"Makiyama","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2023.111112_b0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-019-2033-x","article-title":"Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study","volume":"17","author":"Rinaldi","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejrad.2023.111112_b0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jhep.2016.10.017","article-title":"Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication","volume":"66","author":"van der Meer","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0090","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/jac\/dks269","article-title":"A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy","volume":"67","author":"Chang","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejrad.2023.111112_b0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1478-3231.2004.0956.x","article-title":"Risk factors for hepatocellular carcinoma in hepatitis C patients with sustained virologic response to interferon therapy","volume":"24","author":"Iwasaki","year":"2004","journal-title":"Liver Int."},{"key":"10.1016\/j.ejrad.2023.111112_b0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1440-1746.2005.03800.x","article-title":"Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy","volume":"20","author":"Tokita","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0105","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"UK, Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis","volume":"64","author":"Foster","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0110","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/ciz359","article-title":"Dynamic evaluation of liver fibrosis to assess the risk of hepatocellular carcinoma in patients with chronic hepatitis C who achieved sustained virologic response","volume":"70","author":"Toyoda","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejrad.2023.111112_b0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with Liver Biopsy and Fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2023.111112_b0120","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jgh.12915","article-title":"Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection","volume":"30","author":"Toyoda","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cgh.2018.10.038","article-title":"Factors associated with increased risk of de novo or recurrent hepatocellular carcinoma in patients with cirrhosis treated with direct-acting antivirals for HCV infection","volume":"17","author":"Degasperi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0130","doi-asserted-by":"crossref","first-page":"19698","DOI":"10.3390\/ijms160819698","article-title":"Hepatocellular carcinoma in patients with a sustained response to anti-hepatitis C therapy","volume":"16","author":"D\u2019Ambrosio","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejrad.2023.111112_b0135","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1053\/j.gastro.2017.03.039","article-title":"Hepatitis C virus infection care pathway-A report from the American Gastroenterological Association institute HCV care pathway work group","volume":"152","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejrad.2023.111112_b0140","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/jgh3.12331","article-title":"Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients-Relationship to smoking and alcohol","volume":"4","author":"Matsuura","year":"2020","journal-title":"JGH Open."},{"key":"10.1016\/j.ejrad.2023.111112_b0145","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.cgh.2013.11.033","article-title":"Osaka Liver Forum, Post-treatment levels of \u03b1-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy","volume":"12","author":"Oze","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jmv.21488","article-title":"Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus","volume":"81","author":"Tamori","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejrad.2023.111112_b0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/apt.15825","article-title":"Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: A prospective serial follow-up MRI study","volume":"52","author":"Kumada","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejrad.2023.111112_b0160","doi-asserted-by":"crossref","unstructured":"American Diabetes Association, Diagnosis and classification of diabetes mellitus, Diabetes Care. 33. Supplement 1 (2010) S62\u2013S69, 10.2337\/dc10-S062.","DOI":"10.2337\/dc10-S062"},{"key":"10.1016\/j.ejrad.2023.111112_b0165","first-page":"307","article-title":"Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology, Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2023.111112_b0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting Intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J. Chiropr. Med."},{"key":"10.1016\/j.ejrad.2023.111112_b0175","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jhep.2014.07.010","article-title":"Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma","volume":"1 Supplement: 61(Supplement)","author":"Hoshida","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0180","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/v10100531","article-title":"Molecular mechanisms of hepatocarcinogenesis following sustained virological response in patients with chronic hepatitis C virus infection","volume":"10","author":"Hayes","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ejrad.2023.111112_b0185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/jgh.14530","article-title":"Liver stiffness measurements in chronic hepatitis C: treatment evaluation and risk assessment","volume":"34","author":"Nakagomi","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0190","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.dld.2018.02.010","article-title":"Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals","volume":"50","author":"Ravaioli","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejrad.2023.111112_b0195","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejrad.2023.111112_b0200","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.cgh.2018.11.046","article-title":"Prediction of hepatocellular carcinoma after sustained virological responses using magnetic resonance elastography","volume":"17","author":"Higuchi","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0205","doi-asserted-by":"crossref","unstructured":"T. Kumada, H. Toyoda, S. Yasuda, Y. Sone, S. Ogawa, K. Takeshima, T. Tada, T. Ito, Y. Sumida, J. Tanaka, Prediction of hepatocellular carcinoma by liver stiffness measurements using magnetic resonance elastography after eradicating hepatitis C virus, Clin. Transl. Gastroenterol. 12 (2021) e00337, 10.14309\/ctg.0000000000000337.","DOI":"10.14309\/ctg.0000000000000337"},{"key":"10.1016\/j.ejrad.2023.111112_b0210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"APRICOT Clinical Investigators, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2023.111112_b0215","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2023.111112_b0220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2006.09.020","article-title":"Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C","volume":"46","author":"Halfon","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2023.111112_b0225","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1148\/radiol.2021202232","article-title":"Noninvasive staging of liver fibrosis using 5\u2013minute delayed dual-energy CT: comparison with US elastography and correlation with histologic findings","volume":"298","author":"Marri","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2023.111112_b0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.510230104","article-title":"The hepatic microcirculation in the isolated perfused human liver","volume":"23","author":"Villeneuve","year":"1996","journal-title":"Hepatology"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23004266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23004266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:37:59Z","timestamp":1759995479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X23004266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"alternative-id":["S0720048X23004266"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.111112","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver fibrosis estimated using extracellular volume fraction obtained from dual-energy CT as a risk factor for hepatocellular carcinoma after sustained virologic response: A preliminary case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.111112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111112"}}